Atezolizumab plus bevacizumab for patients with Child-Pugh-B in hepatocellular carcinoma

被引：2
|
作者：
Itoh, Shinji [1 ]
Ikeda, Masafumi [2 ]
机构：
[1] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan
[2] Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Japan
来源：
HEPATOBILIARY SURGERY AND NUTRITION | 2022年
关键词：
D O I：
10.21037/hbsn-22-432
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Atezolizumab plus bevacizumab in Child-Pugh B advanced hepatocellular carcinoma patients
    Kim, Hyeyeong
    Cheon, Jaekyung
    Ha, Yeongjung
    Kim, Han Sang
    Kim, Chang Gon
    Kim, Ilhwan
    Kim, Chan
    Jung, Sang-Hoon
    Chon, Hong Jae
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [2] Atezolizumab plus bevacizumab in patients with child-Pugh B advanced hepatocellular carcinoma
    Cheon, Jaekyung
    Kim, Hyeyeong
    Kim, Han Sang
    Kim, Chang Gon
    Kim, Ilhwan
    Kang, Beodeul
    Kim, Chan
    Jung, Sanghoon
    Ha, Yeonjung
    Chon, Hong Jae
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [3] Survival outcomes from atezolizumab plus bevacizumab versus Lenvatinib in Child Pugh B unresectable hepatocellular carcinoma patients
    Rimini, Margherita
    Persano, Mara
    Tada, Toshifumi
    Suda, Goki
    Shimose, Shigeo
    Kudo, Masatoshi
    Cheon, Jaekyung
    Finkelmeier, Fabian
    Lim, Ho Yeong
    Presa, Jose
    Salani, Francesca
    Lonardi, Sara
    Piscaglia, Fabio
    Kumada, Takashi
    Sakamoto, Naoya
    Iwamoto, Hideki
    Aoki, Tomoko
    Chon, Hong Jae
    Himmelsbach, Vera
    Schirripa, Marta
    Montes, Margarida
    Vivaldi, Caterina
    Solda, Caterina
    Hiraoka, Atsushi
    Sho, Takuya
    Niizeki, Takashi
    Nishida, Naoshi
    Steup, Christoph
    Hirooka, Masashi
    Kariyama, Kazuya
    Tani, Joji
    Atsukawa, Masanori
    Takaguchi, Koichi
    Itobayashi, Ei
    Fukunishi, Shinya
    Tsuji, Kunihiko
    Ishikawa, Toru
    Tajiri, Kazuto
    Ochi, Hironori
    Yasuda, Satoshi
    Toyoda, Hidenori
    Ogawa, Chikara
    Nishimura, Takashi
    Hatanaka, Takeshi
    Kakizaki, Satoru
    Shimada, Noritomo
    Kawata, Kazuhito
    Tada, Fujimasa
    Ohama, Hideko
    Nouso, Kazuhiro
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (10) : 7565 - 7577
  • [4] Survival outcomes from atezolizumab plus bevacizumab versus Lenvatinib in Child Pugh B unresectable hepatocellular carcinoma patients
    Margherita Rimini
    Mara Persano
    Toshifumi Tada
    Goki Suda
    Shigeo Shimose
    Masatoshi Kudo
    Jaekyung Cheon
    Fabian Finkelmeier
    Ho Yeong Lim
    José Presa
    Francesca Salani
    Sara Lonardi
    Fabio Piscaglia
    Takashi Kumada
    Naoya Sakamoto
    Hideki Iwamoto
    Tomoko Aoki
    Hong Jae Chon
    Vera Himmelsbach
    Marta Schirripa
    Margarida Montes
    Caterina Vivaldi
    Caterina Soldà
    Atsushi Hiraoka
    Takuya Sho
    Takashi Niizeki
    Naoshi Nishida
    Christoph Steup
    Masashi Hirooka
    Kazuya Kariyama
    Joji Tani
    Masanori Atsukawa
    Koichi Takaguchi
    Ei Itobayashi
    Shinya Fukunishi
    Kunihiko Tsuji
    Toru Ishikawa
    Kazuto Tajiri
    Hironori Ochi
    Satoshi Yasuda
    Hidenori Toyoda
    Chikara Ogawa
    Takashi Nishimura
    Takeshi Hatanaka
    Satoru Kakizaki
    Noritomo Shimada
    Kazuhito Kawata
    Fujimasa Tada
    Hideko Ohama
    Kazuhiro Nouso
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 7565 - 7577
  • [5] Real-world use of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis
    D'Alessio, Antonio
    Weinmann, Arndt
    Galle, Peter R.
    Fulgenzi, Claudia Angela Maria
    Bettinger, Dominik
    Bengsch, Bertram
    Vogel, Arndt
    Balcar, Lorenz
    Scheiner, Bernhard
    Navaid, Musharraf
    Naqash, Abdul Rafeh
    Personeni, Nicola
    Pressiani, Tiziana
    Sharma, Rohini
    Pinter, Matthias
    Cortellini, Alessio
    Rimassa, Lorenza
    Pinato, David James
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [6] Efficacy and safety of atezolizumab and bevacizumab in the realworld treatment of Child Pugh B patients with advanced hepatocellular carcinoma
    Stella, Leonardo
    Ponziani, Francesca
    Santopaolo, Francesco
    Hollande, Clemence
    Gasbarrini, Antonio
    Sidali, Sabrina
    Pompili, Maurizio
    Bouattour, Mohamed
    JOURNAL OF HEPATOLOGY, 2023, 78 : S578 - S579
  • [7] Survival outcomes from Atezolizumab plus Bevacizumab versus Lenvatinib versus Sorafenib in Child Pugh B unresectable hepatocellular carcinoma patients
    Rimini, Margherita
    Persano, Mara
    Tada, Toshifumi
    Suda, Goki
    Shigeo, Shimose
    Kudo, Masatoshi
    Cheon, Jaekyung
    Finkelmeier, Fabian
    Lim, Ho Yeong
    Presa, Jose
    Lonardi, Sara
    Piscaglia, Fabio
    Chon, Hong Jae
    Masi, Gianluca
    Scartozzi, Mario
    Cascinu, Stefano
    Casadei-Gardini, Andrea
    JOURNAL OF HEPATOLOGY, 2023, 78 : S592 - S592
  • [8] UNMET SYSTEMIC THERAPY NEED FOR CHILD-PUGH CLASS B PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA - COMPARISON OF ATEZOLIZUMAB PLUS BEVACIZUMAB AND LENVATINIB
    Ohama, Hideko
    Hiraoka, Atsushi
    Tada, Toshifumi
    Hirooka, Masashi
    Kariyama, Kazuya
    Itobayashi, Ei
    Kunihiko, Tsuji
    Ishikawa, Toru
    Toyoda, Hidenori
    Hatanaka, Takeshi
    Kakizaki, Satoru
    Naganuma, Atsushi
    Matono, Tomomitsu
    Tada, Fujimasa
    Nouso, Kazuhiro
    Hiasa, Yoichi
    Kumada, Takashi
    HEPATOLOGY, 2023, 78 : S1907 - S1907
  • [9] Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis: A real-world study
    D'Alessio, Antonio
    Fulgenzi, Claudia Angela Maria
    Nishida, Naoshi
    Schoenlein, Martin
    von Felden, Johann
    Schulze, Kornelius
    Wege, Henning
    Gaillard, Vincent E.
    Saeed, Anwaar
    Wietharn, Brooke
    Hildebrand, Hannah
    Wu, Linda
    Ang, Celina
    Marron, Thomas U.
    Weinmann, Arndt
    Galle, Peter R.
    Bettinger, Dominik
    Bengsch, Bertram
    Vogel, Arndt
    Balcar, Lorenz
    Scheiner, Bernhard
    Lee, Pei-Chang
    Huang, Yi-Hsiang
    Amara, Suneetha
    Muzaffar, Mahvish
    Naqash, Abdul Rafeh
    Cammarota, Antonella
    Personeni, Nicola
    Pressiani, Tiziana
    Sharma, Rohini
    Pinter, Matthias
    Cortellini, Alessio
    Kudo, Masatoshi
    Rimassa, Lorenza
    Pinato, David J.
    HEPATOLOGY, 2022, 76 (04) : 1000 - 1012
  • [10] Comparison between Atezolizumab Plus Bevacizumab and Lenvatinib for Hepatocellular Carcinoma in Patients with Child-Pugh Class B in Real-World Clinical Settings
    Ohama, Hideko
    Hiraoka, Atsushi
    Tada, Toshifumi
    Hirooka, Masashi
    Kariyama, Kazuya
    Tani, Joji
    Atsukawa, Masanori
    Takaguchi, Koichi
    Itobayashi, Ei
    Fukunishi, Shinya
    Tsuji, Kunihiko
    Ishikawa, Toru
    Tajiri, Kazuto
    Ochi, Hironori
    Yasuda, Satoshi
    Toyoda, Hidenori
    Ogawa, Chikara
    Nishimura, Takashi
    Hatanaka, Takeshi
    Kakizaki, Satoru
    Shimada, Noritomo
    Kawata, Kazuhito
    Naganuma, Atsushi
    Kosaka, Hisashi
    Matono, Tomomitsu
    Shibata, Hiroshi
    Aoki, Tomoko
    Tada, Fujimasa
    Nouso, Kazuhiro
    Morishita, Asahiro
    Tsutsui, Akemi
    Nagano, Takuya
    Itokawa, Norio
    Okubo, Tomomi
    Arai, Taeang
    Imai, Michitaka
    Koizumi, Yohei
    Nakamura, Shinichiro
    Iijima, Hiroko
    Kaibori, Masaki
    Hiasa, Yoichi
    Kudo, Masatoshi
    Kumada, Takashi
    ONCOLOGY, 2023, 101 (09) : 542 - 552
12345